Cardiometabolic risk is a condition in which the possibility of developing a cardiovascular disease is high. Specific factors that can cause this increased risk include Diabetes mellitus, Hypertension, Hyperglycemia, obesity and insulin resistance. Over the past few years, medical research has been providing inputs to manage Cardiometabolic risk and address several diseases which are associated with the increasing number of serious underlying health problems.
It is important to be aware of the management of these risk factors, which help prevent the possibility of developing serious ailments successively. To address the health problems, healthy lifestyle changes and a right program suggested by the physicians are the most important way to lower your risk.
It is of utmost importance for the healthcare professionals to keep abreast of the latest scientific and clinical developments in the areas that could make a real difference in improving your medical treatments. In order to have an effective approach towards rapidly growing epidemic of cardiovascular and metabolic diseases it requires an integrated management of all aspects of cardiometabolic risk. The 11th Annual Cardiometabolic Health Congress (CMHC) is one such opportunity to update oneself with the latest technological advancements and scientific/clinical developments in cardiometabolic disorders. This event will be held during October 05 - 08, 2016 at the Sheraton Boston Hotel, Boston, Massachusetts. The conference offers real time workshops, debates, symposia and real time case studies that add up to 27.25 CME credit hours. The target audience for this conference is advanced-level clinicians and expert faculty of all disciplines responsible for the prevention, diagnosis and management of Cardiometabolic risk.
Several renowned speakers will be addressing the conference and providing valuable insights in the field. Dr. Jay S. Skyler, MD, M.A.C.P ,Internal Medicine and General Medicine Miami, Florida,is the Deputy Director for Clinical Research and Academic Programs at the Diabetes Research Institute and also a member of the University of Miami Interdisciplinary Stem Cell Institute.His career in diabetes spans nearly five decades and has continuous research support from The National Institute of Health (NIH) since 1979. He was the President of the American Diabetes Association and the founding Editor-in-Chief of Diabetes Care.
Another speaker, Dr. Robert E. Ratner ,MD, FACP, FACE, is the Chief Scientific & Medical Officer for the American Diabetes Association. He underwent fellowship training in Endocrinology and Metabolism at Harvard Medical School and the Joslin Diabetes Center in Boston. He completed six years of service on the Steering Committee of the National Diabetes Education Program (NDEP). He has served on the Board of Directors of the National Certification Board for Diabetes Education and the American Association of Diabetes Educators. His research interests arediabetes therapeutics and complications. He is also the author of more than 150 original scientific articles and 20 book chapters.